Skip to main content
logo
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
1.660
-0.090 (-5.14%)
Oct 30, 2026, 10:43 AM EDT - Market open

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
25731943--
Market Cap Growth
-61.36%278.47%-55.39%---
Enterprise Value
046-2733--
Last Close Price
1.757.902.347.63--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
79.8618.241.986.06--
PB Ratio
1.034.010.495.87--
P/TBV Ratio
1.154.010.495.87--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.5911.43-4.60--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-----1.38-2.74
Net Debt / Equity Ratio
-1.09-1.14-0.99-1.06-0.92-0.92
Asset Turnover
0.010.120.371.01--
Quick Ratio
8.234.5710.613.360.311.48
Current Ratio
8.574.9111.113.840.321.50
Return on Equity (ROE)
-107.62%-93.92%-69.95%---
Return on Assets (ROA)
-60.80%-53.62%-42.95%-69.12%-39.59%-
Return on Capital Employed (ROCE)
-135.70%-155.30%-46.50%-105.90%38.60%-223.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-192.34%-36.89%-84.35%-5.02%--
Buyback Yield / Dilution
-8.40%-12.00%-203.34%-413.65%88.49%-
SEC Filings: 10-K · 10-Q